Form 8-K - Current report:
SEC Accession No. 0001213900-26-044905
Filing Date
2026-04-17
Accepted
2026-04-17 07:31:18
Documents
16
Period of Report
2026-04-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0286584-8k_pmgc.htm   iXBRL 8-K 47053
2 FORM OF SECURITIES PURCHASE AGREEMENT ea028658401ex10-1.htm EX-10.1 159956
3 FORM OF PRE-PAID PURCHASE ea028658401ex10-2.htm EX-10.2 60059
4 FORM OF GUARANTY ea028658401ex10-3.htm EX-10.3 56636
5 FORM OF PLEDGE AGREEMENT ea028658401ex10-4.htm EX-10.4 54246
6 PRESS RELEASE DATED APRIL 17, 2026 ea028658401ex99-1.htm EX-99.1 10084
  Complete submission text file 0001213900-26-044905.txt   654178

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE elab-20260416.xsd EX-101.SCH 3026
8 XBRL LABEL FILE elab-20260416_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE elab-20260416_pre.xml EX-101.PRE 22366
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0286584-8k_pmgc_htm.xml XML 3205
Mailing Address 120 NEWPORT CENTER DRIVE NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 26869397
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)